Terms: = Lung cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
24 results:
1. Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis.
Cornish N; Haycock P; Brenner H; Figueiredo JC; Galesloot TE; Grant RC; Johansson M; Mariosa D; McKay J; Pai R; Pellatt AJ; Samadder NJ; Shi J; Thibord F; Trégouët DA; Voegele C; Thirlwell C; Mumford A; Langdon R;
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38124529
[TBL] [Abstract] [Full Text] [Related]
2. DNMT3A-mediated high expression of circ_0057504 promotes benzo[a]pyrene-induced DNA damage via the nono-SFPQ complex in human bronchial epithelial cells.
Qiu M; Zhang N; Yao S; Zhou H; Chen X; Jia Y; Zhang H; Li X; Jiang Y
Environ Int; 2022 Dec; 170():107627. PubMed ID: 36399942
[TBL] [Abstract] [Full Text] [Related]
3. Stabilization of SAMHD1 by nono is crucial for Ara-C resistance in AML.
Zhang F; Sun J; Tang X; Liang Y; Jiao Q; Yu B; Dai Z; Yuan X; Li J; Yan J; Zhang Z; Fan S; Wang M; Hu H; Zhang C; Lv XB
Cell Death Dis; 2022 Jul; 13(7):590. PubMed ID: 35803902
[TBL] [Abstract] [Full Text] [Related]
4. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
5. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing nono.
Shi X; Huang X; Chen R; Li Y; Xu Y; Zhang W; Zhu Q; Zha X; Wang J
Clin Exp Metastasis; 2021 Dec; 38(6):551-571. PubMed ID: 34714466
[TBL] [Abstract] [Full Text] [Related]
6. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the nono/STAT3 axis.
Qin Z; Tong H; Li T; Cao H; Zhu J; Yin S; He W
Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34549307
[TBL] [Abstract] [Full Text] [Related]
7. XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition.
Patidar PL; Viera T; Morales JC; Singh N; Motea EA; Khandelwal M; Fattah FJ
Sci Rep; 2020 Aug; 10(1):14253. PubMed ID: 32859985
[TBL] [Abstract] [Full Text] [Related]
8. ABO blood group relationships to kidney transplant recipient and graft outcomes.
Ng MSY; Ullah S; Wilson G; McDonald S; Sypek M; Mallett AJ
PLoS One; 2020; 15(7):e0236396. PubMed ID: 32702043
[TBL] [Abstract] [Full Text] [Related]
9. An RNA-binding-protein, nono governs energy metabolism by regulating NAMPT in lung cancer.
Kim SJ; Ju JS; Park SS; Suh YA; Yoo HJ; Choi EK; Seong-Yun Jeong ; Shin Y; Park YY
Biochem Biophys Res Commun; 2020 Jul; 528(2):376-382. PubMed ID: 32087970
[TBL] [Abstract] [Full Text] [Related]
10. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring nono-TFE3 fusion gene.
Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y
Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953
[TBL] [Abstract] [Full Text] [Related]
11. MetaLnc9 Facilitates lung cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.
Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M
Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases.
Ahmed KA; Kim S; Arrington J; Naghavi AO; Dilling TJ; Creelan BC; Antonia SJ; Caudell JJ; Harrison LB; Sahebjam S; Gray JE; Etame AB; Johnstone PA; Yu M; Perez BA
J Neurooncol; 2017 Jun; 133(2):331-338. PubMed ID: 28466250
[TBL] [Abstract] [Full Text] [Related]
13. Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line.
Masuelli L; Benvenuto M; Di Stefano E; Mattera R; Fantini M; De Feudis G; De Smaele E; Tresoldi I; Giganti MG; Modesti A; Bei R
Oncotarget; 2017 May; 8(21):34405-34422. PubMed ID: 28159921
[TBL] [Abstract] [Full Text] [Related]
14. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.
Chen Z; Li JL; Lin S; Cao C; Gimbrone NT; Yang R; Fu DA; Carper MB; Haura EB; Schabath MB; Lu J; Amelio AL; Cress WD; Kaye FJ; Wu L
J Clin Invest; 2016 Jun; 126(6):2267-79. PubMed ID: 27140397
[TBL] [Abstract] [Full Text] [Related]
15. Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma.
Vavougios GD; Solenov EI; Hatzoglou C; Baturina GS; Katkova LE; Molyvdas PA; Gourgoulianis KI; Zarogiannis SG
Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(7):L677-86. PubMed ID: 26254420
[TBL] [Abstract] [Full Text] [Related]
16. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
[TBL] [Abstract] [Full Text] [Related]
17. Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey.
Urun Y; Utkan G; Cangir AK; Oksuzoglu OB; Ozdemir N; Oztuna DG; Kocaman G; Coşkun HŞ; Kaplan MA; Yuksel C; Demirkazik A; Icli F
Asian Pac J Cancer Prev; 2013; 14(5):2801-3. PubMed ID: 23803034
[TBL] [Abstract] [Full Text] [Related]
18. Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.
Weisbrod AB; Nilubol N; Weinstein LS; Simonds WF; Libutti SK; Jensen RT; Marx SJ; Kebebew E
J Clin Endocrinol Metab; 2013 Jan; 98(1):E109-14. PubMed ID: 23093487
[TBL] [Abstract] [Full Text] [Related]
19. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract] [Full Text] [Related]
20. Anti-inflammatory agents as cancer therapeutics.
Kashfi K
Adv Pharmacol; 2009; 57():31-89. PubMed ID: 20230759
[TBL] [Abstract] [Full Text] [Related]
[Next]
